Astrazeneca Ab

Ulrika Yngve

Abdelmalik Slassi

Louise G Edwards

Methvin Benjamin Isaac

Tao Xin

Annika Kers

Thomas M Stormann

David Wensbo

Jeremy Nicholas Burrows

Jalaj Arora

Tomislav Stefanac

Donald A McLeod

Alexander Minidis

Martin Johansson

Helena Gyback

John Malmberg

Erica Tjerneld

Karin Oscarsson

Mangus Waldman

Christoffer Osterwall

Per I Arvidsson

Imidazole substituted pyrimidines and pharmaceutically acceptable salts thereof; pharmaceutical formulations containing such pyrimidines; the use of such compounds in therapy; the use of such compounds for the treatment of conditions associated with glycogen synthase kinase-3 related disorders, such as Alzheimer's disease, as well as methods of treatment of such disorders comprising administering to subjects in need of such treatment therapeutically effective amounts of such compounds.

Imidazole substituted pyrimidines

The present invention relates to new compounds of formula I, a process for their preparation and new intermediates prepared therein, pharmaceutical formulations containing compounds of the formula I and to the use of compounds of the formula I in therapy.

Compounds

Growing community of inventors

Södertälje, Sweden

Ulrika Yngve